| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |